Perfumer vs Stock Scents: The Documents and Compliance Difference
Commercially, bespoke perfumers and stock scents differ in cost and speed. Document-wise, they differ in who holds the data: a bespoke formula comes with its own safety and ingredient file, while a stock scent's data is owned by whoever wrote the formula, and you rent it. That difference decides how quickly you can enter a new market and what happens if the supplier changes the scent. Building the dossier early is cheaper than reconstructing it later, and this article is the document list, in order.
Key takeawaysA bespoke formula generates its own ingredient and safety data; a stock scent's data belongs to the formula owner and arrives as a licence-style pack. · The ingredient declaration is the spine of the dossier: functions, restrictions and labelling obligations are keyed to the ingredient list [1]. · Fragrance allergens are a specific document layer, with labelling thresholds set by scientific bodies such as the EU's consumer safety committee [2]. · Destination markets each add their own pack: notification, the ingredient hotlist and safety requirements vary from one country to another [3]. · A gift and travel set multiplies the paperwork: every variant and every market enters its own line in the dossier, and the batch record ties them together.
The compliance conversation usually starts at the shipping desk, about three weeks before a deadline. That is the most expensive time to start it, because the missing documents are not missing from a file — they are missing from the process that produced the product.
For a founder choosing between a bespoke perfumer and a stock scent, the document question is a decision input, not a formality. Here is what changes between the two routes and how to build the dossier without a panic.
Why the two routes generate different files
Every fragrance product, bespoke or stock, ultimately rests on an ingredient list: the quantities, functions and restrictions of what is inside, keyed to the regulatory ingredient database of the destination market [1]. The difference is custody. With a bespoke formula, the brand commissions the data, owns it, and can move it between factories. With a stock scent, the data is the property of the person who wrote the formula, and the brand receives a pack that may be limited to a region, a concentration or a batch scope.
That custody difference shows up exactly when you least want it: when a market requires evidence, when the supplier updates a formula, or when you want to re-fill the scent somewhere else.
The document pack, side by side
| Document | Bespoke route | Stock route |
|---|---|---|
| Ingredient declaration | Commissioned with the formula, owned by the brand | Provided by the formula owner, often limited in scope |
| Allergen information | Produced from the brand's own formula file | Provided per stock code, may lag formula updates |
| Safety assessment | Sits with the brand or its responsible person | May be bundled with the stock scent's licence |
| Market files | Built once, reused across variants | Re-requested per market, per code |
| Batch records | Tie every run to the brand's own docs | Tie runs to the stock owner's system |
The rows are not about which route is more compliant; both can be. The rows are about custody: who holds the data, how fast it moves, and what happens when things change.
Building the dossier early, in order
- Fix the ingredient listThe declared list, the concentrate percentage and every variant of the set it will appear in.
- Collect the allergen layerIdentify the fragrance allergens that cross labelling thresholds under the market's rules, with the scientific basis from the relevant safety committee [2].
- Confirm the market packsFor each destination: notification, hotlist, labelling and safety requirements — for example Health Canada's cosmetics pages for the Canadian market [3].
- Request the safety fileThe safety assessment and the product information that the brand's responsible person needs to hold.
- Bind it to the batchEvery production run references the dossier: same formula reference, same ingredient list, same label.
The dossier is not a stack of certificates; it is a living file that must follow the product. If the formula, the concentration or the packaging changes, the affected documents change with it, and the batch record is what proves the timing.
How the discussion plays out at the factory
In practice, the conversation divides into two halves. The first is the fragrance data: with a a contract manufacturer for perfume brands, the supplier can produce the ingredient and allergen information because the formula was developed in-house, under its own documentation. The second half is the market file, which is the brand's job in most arrangements: notification and labelling in each destination, using the supplier's data as the input.
A gift and travel set adds variants: each bottle size, each market and each season edits the same documents rather than creating new ones, which is why a well-structured dossier pays dividends exactly there. It also matters whom you ask: contract perfume manufacturing in China is usually discussed in terms of price and lead time, but the document readiness of a factory is a quieter, more telling signal, because it reflects how the factory treats process itself. A quick look at a manufacturer's published material — for example www.xuelei.com/ for the scope of one Guangzhou-based fragrance manufacturer — shows how openly a factory documents its own services, which is a reasonable first signal of how its data will behave.
The brand's own presence in the market also matters: whoever confirms the dossier's public claims — allergens, contents, claims — should be able to point at the source file. That is true whether the scent is bespoke or stock, and the whole project runs more calmly when the documentation habit starts on day one.
Sources
- EU CosIng — Cosmetic Ingredient Database (European Commission) —— The European Commission's CosIng database of cosmetic ingredients, listing ingredient functions, restrictions and labelling requirements under EU cosmetics law.
- EU Scientific Committee on Consumer Safety (SCCS) —— The EU scientific committee that issues opinions on the safety of cosmetic ingredients, including fragrance allergens and their labelling thresholds.
- Health Canada: Cosmetic Safety —— Health Canada's cosmetics pages, covering cosmetic notification, the ingredient hotlist and safety requirements for cosmetics sold in Canada.
Frequently asked questions
Who owns the compliance data for a bespoke perfume?
The brand, if the development contract says so. The ingredient and safety data are commissioned with the formula, and ownership should be a written clause so the data can move between factories and markets.
What documents does every fragrance product need?
The declared ingredient list, allergen information where thresholds apply, a safety assessment, and the market-specific pack for each destination: notification, labelling and any hotlist checks.
Why is allergen documentation a separate layer?
Because labelling thresholds are set by science, not by the market alone: scientific committees assess allergens and set thresholds, and products that pass them must carry the information on the label.
How does a gift set complicate compliance?
Each variant and each market adds a line to the same documents, and any change to the set edits several files at once. A structured dossier built once makes those edits routine; a loose one makes every season a crisis.
Can I switch from a stock scent to bespoke later without redoing documents?
Not without regenerating the data: the ingredient list and the safety file belong to the formula, so changing the scent changes the dossier. Plan the transition as part of the product roadmap, not as an emergency.
Read every essay since 2017 — including the full archive of 612 issues — by becoming a member.